Potential Drug Target: Olfactory Receptor OR51G1 (G79324)
Potential Drug Target: Olfactory Receptor OR51G1
Olfactory receptor OR51G1 is a protein that is expressed in the sweat glands and is responsible for sensing odor. OR51G1 has been identified as a potential drug target and a biomarker for various diseases, including cancer, diabetes, and neurological disorders.
OR51G1 is a member of the Olfactory receptor family, which is a large superfamily of G protein-coupled receptors (GPCRs) that are involved in sensory perception. GPCRs are transmembrane proteins that are composed of an extracellular portion, a transmembrane region, and an intracellular portion. The transmembrane region of GPCRs contains a catalytic center, which is responsible for the chemical reaction that occurs when the GPCR is activated, as well as a regulatory region that is involved in the regulation of the GPCR.
OR51G1 is a 194 amino acid protein that is expressed in the sweat glands, which are located in the peripheral area of 鈥嬧?媡he body. The sweat glands are responsible for releasing sweat, which carries water, electrolytes, and other substances from the body. OR51G1 is located in the basolateral portion of the sweat glands and is involved in the perception of odor.
OR51G1 has been identified as a potential drug target due to its involvement in various diseases. One of the main reasons for its potential as a drug target is its expression in multiple tissues and organs, including the sweat glands, which make it a potential target for drugs that can modify its function. Additionally, OR51G1 is involved in several signaling pathways that are involved in various diseases, including cancer, diabetes, and neurological disorders.
OR51G1 is involved in the sensing of volatile organic compounds (VOCs), which are molecules that are produced by bacteria and other microorganisms. VOCs are able to activate the OR51G1 protein and are involved in the perception of odors. Additionally, OR51G1 is involved in the regulation of the production of sweat, which is involved in the regulation of body temperature.
In cancer, OR51G1 has been identified as a potential drug target due to its involvement in the regulation of cell growth and differentiation. Additionally, OR51G1 has been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed in the body. This suggests that OR51G1 may be involved in the development and progression of cancer.
In diabetes, OR51G1 has been identified as a potential drug target due to its involvement in the regulation of insulin sensitivity and inflammation. Additionally, OR51G1 has been shown to be involved in the regulation of inflammation, which is a key factor in the development of various diseases, including diabetes.
In neurological disorders, OR51G1 has been identified as a potential drug target due to its involvement in the regulation of pain perception and neurotransmitter release. Additionally, OR51G1 has been shown to be involved in the regulation of motor function and neurodegeneration, which are key factors in the development of various neurological disorders.
Despite its potential as a drug target, OR51G1 has not yet been studied extensively, and more research is needed to fully understand its role in the regulation of various diseases. Additionally, the development of drugs that can specifically modulate OR51G1 function may be a promising strategy for the treatment of various diseases.
Protein Name: Olfactory Receptor Family 51 Subfamily G Member 1
Functions: Odorant receptor
The "OR51G1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR51G1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR51G2 | OR51H1 | OR51I1 | OR51I2 | OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1 | OR51V1 | OR52A1 | OR52A4P | OR52A5 | OR52B2 | OR52B4 | OR52B6 | OR52D1 | OR52E1 | OR52E2 | OR52E4 | OR52E5 | OR52E6 | OR52E8 | OR52H1 | OR52I1 | OR52I2 | OR52J3 | OR52K1 | OR52K2 | OR52K3P | OR52L1 | OR52M1 | OR52N1 | OR52N4 | OR52N5 | OR52R1 | OR52W1 | OR52Z1P | OR56A1 | OR56A3 | OR56A4 | OR56A5 | OR56B1 | OR56B4 | OR5A1 | OR5A2 | OR5AC1 | OR5AC2 | OR5AK2 | OR5AK4P | OR5AN1 | OR5AP2 | OR5AR1 | OR5AS1 | OR5AU1 | OR5B12 | OR5B17 | OR5B2 | OR5B21 | OR5B3 | OR5BA1P | OR5C1 | OR5D13 | OR5D14 | OR5D16 | OR5D17P | OR5D18 | OR5E1P | OR5F1 | OR5H1 | OR5H14 | OR5H15 | OR5H2 | OR5H4P | OR5H6 | OR5I1 | OR5K1 | OR5K2 | OR5K3 | OR5K4 | OR5L1 | OR5L2 | OR5M1 | OR5M10 | OR5M11 | OR5M3 | OR5M4P | OR5M8 | OR5M9 | OR5P1P | OR5P2 | OR5P3 | OR5T1 | OR5T2 | OR5T3 | OR5V1 | OR5W2 | OR6A2 | OR6B1
